Concepedia

Wendy Chen

WC

Statistics

Publications

36

Citations

2.5K

H-Index

23

Active since

1994

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Sheba Medical Center

Johns Hopkins University

Johns Hopkins Medicine

Tel Aviv University

Wendy Chen is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and immunotherapy.

ORCID

Publications per year

1994–2022

36

Publications

36

Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2

Ethylin Wang Jabs, Xiang Li, Alan F. Scott et al. · Nature Genetics · 1994 · 472 citations

, , +8

Maternally Expressed Gene 3 (MEG3) Noncoding Ribonucleic Acid: Isoform Structure, Expression, and Functions

Xun Zhang, Kimberley A. Rice, Yingying Wang et al. · Endocrinology · 2009 · 338 citations · Full text

, , +17

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial

Michael Wang, Luis Fayad, Nicolaus A. Wagner‐Bartak et al. · The Lancet Oncology · 2012 · 297 citations

, , +16

Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial

Michael Wang, Hun Ju Lee, Hubert H. Chuang et al. · The Lancet Oncology · 2015 · 214 citations

, , +10

Long‐term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib

Preetesh Jain, Rashmi Kanagal‐Shamanna, Shaojun Zhang et al. · British Journal of Haematology · 2018 · 115 citations · Full text

, , +16

1–5 of 36